{"address1": "5005 McConnell Avenue", "city": "Los Angeles", "state": "CA", "zip": "90066", "country": "United States", "phone": "310 665 2928", "fax": "310 665 2963", "website": "https://www.armatapharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.", "fullTimeEmployees": 60, "companyOfficers": [{"maxAge": 1, "name": "Dr. Deborah L. Birx M.D.", "age": 67, "title": "CEO & Director", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 536431, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David D. House", "title": "Senior VP of Finance & Principal Financial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Hubbard", "title": "Vice President of Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pierre  Kyme Ph.D.", "title": "Chief Business Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://ir.ampliphibio.com/phoenix.zhtml?c=84981&p=irol-stockquote", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.46, "open": 1.42, "dayLow": 1.38, "dayHigh": 1.44, "regularMarketPreviousClose": 1.46, "regularMarketOpen": 1.42, "regularMarketDayLow": 1.38, "regularMarketDayHigh": 1.44, "payoutRatio": 0.0, "beta": 0.895, "forwardPE": -0.91719747, "volume": 4511, "regularMarketVolume": 4511, "averageVolume": 12495, "averageVolume10days": 24830, "averageDailyVolume10Day": 24830, "bid": 0.58, "ask": 0.0, "bidSize": 11, "askSize": 9, "marketCap": 52103668, "fiftyTwoWeekLow": 1.34, "fiftyTwoWeekHigh": 3.85, "priceToSalesTrailing12Months": 10.070288, "fiftyDayAverage": 1.9712, "twoHundredDayAverage": 2.29675, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 169327616, "profitMargins": 0.0, "floatShares": 11035112, "sharesOutstanding": 36183100, "sharesShort": 7691, "sharesShortPriorMonth": 7052, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0002, "heldPercentInsiders": 0.70248, "heldPercentInstitutions": 0.03838, "shortRatio": 0.69, "shortPercentOfFloat": 0.0007, "impliedSharesOutstanding": 36183100, "bookValue": -1.327, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -18916000, "trailingEps": -0.89, "forwardEps": -1.57, "lastSplitFactor": "1:14", "lastSplitDate": 1557446400, "enterpriseToRevenue": 32.727, "enterpriseToEbitda": -4.119, "52WeekChange": -0.6054795, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 1.44, "targetHighPrice": 7.0, "targetLowPrice": 7.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 9291000, "totalCashPerShare": 0.257, "ebitda": -41111000, "totalDebt": 126515000, "quickRatio": 0.208, "currentRatio": 0.234, "totalRevenue": 5174000, "revenuePerShare": 0.143, "returnOnAssets": -0.28704, "grossProfits": -29252000, "freeCashflow": -29402250, "operatingCashflow": -37551000, "revenueGrowth": -0.192, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -8.5336, "financialCurrency": "USD", "symbol": "ARMP", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Armata Pharmaceuticals, Inc.", "longName": "Armata Pharmaceuticals, Inc.", "regularMarketChange": -0.02, "regularMarketDayRange": "1.38 - 1.44", "fullExchangeName": "NYSE American", "averageDailyVolume3Month": 12495, "fiftyTwoWeekLowChange": 0.100000024, "fiftyTwoWeekLowChangePercent": 0.07462688, "fiftyTwoWeekRange": "1.34 - 3.85", "fiftyTwoWeekHighChange": -2.4099998, "fiftyTwoWeekHighChangePercent": -0.625974, "fiftyTwoWeekChangePercent": -60.547947, "dividendDate": 1557446400, "earningsTimestamp": 1742507813, "earningsTimestampStart": 1746442740, "earningsTimestampEnd": 1746792000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.89, "epsForward": -1.57, "epsCurrentYear": -1.94, "priceEpsCurrentYear": -0.742268, "fiftyDayAverageChange": -0.53119993, "fiftyDayAverageChangePercent": -0.2694805, "twoHundredDayAverageChange": -0.85675, "twoHundredDayAverageChangePercent": -0.3730271, "priceToBook": -1.0851545, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Armata Pharmaceuticals Inc.", "nameChangeDate": "2025-04-01", "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 769440600000, "regularMarketChangePercent": -1.36986, "regularMarketPrice": 1.44, "corporateActions": [], "regularMarketTime": 1743537600, "exchange": "ASE", "messageBoardId": "finmb_84546611", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "displayName": "Armata Pharmaceuticals", "trailingPegRatio": null}